Connect with us

Health

Safety in mind as Prescient Therapeutics develops next-generation CAR-T platform – Stockhead

Tragedy struck the CAR-T space this month with a US company halting a trial of its lead therapy after the deaths of two patients….

Published

on

Article feature image

Link copied toclipboard
Tragedy struck the CAR-T space this month with a US company halting a trial of its lead therapy after the deaths of two patients, a sobering reminder of the dangers involved in cell therapy.
The patients reportedly died from immune…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending